Shin Nippon Biomedical Laboratories, Ltd. (JP:2395) has released an update.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Shin Nippon Biomedical Laboratories (SNBL) has announced a collaboration with Astellas Pharma to enhance the drug discovery ecosystem in Tsukuba City by providing non-clinical study support at the SakuLab™-Tsukuba innovation center. SNBL, Japan’s largest nonclinical CRO, will offer its expertise in drug discovery to support startups, academia, and pharmaceutical companies at Tsukuba, one of Japan’s leading life science centers. This partnership aims to accelerate the development of new drugs and advanced technologies within the Tsukuba ecosystem.
For further insights into JP:2395 stock, check out TipRanks’ Stock Analysis page.